Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.27
Delayed Data
As of Jun 22
 +0.005 / +1.89%
Today’s Change
0.03
Today|||52-Week Range
0.35
0.00%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.27
Today’s open0.27
Day’s range0.25 - 0.27
Volume78,941
Average volume (3 months)72,123
Market cap$11.5M
Data as of 3:11pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)+0.02%
P/E ratio--
Price/Sales1.42
Price/Book1.26

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$8.4M
Annual profit (last year)$5.4M
Net profit margin64.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Chief Financial &
Accounting Officer, VP-Finance
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts